Statistics for Optimal sequential enrichment designs for phase II clinical trials
Total visits
views | |
---|---|
Optimal sequential enrichment designs for phase II clinical trials | 264 |
Total visits per month
views | |
---|---|
August 2024 | 0 |
September 2024 | 0 |
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
nihms817890.pdf | 215 |
java.util.UUID:de23e56a-fd2d-487f-9d8f-56c7a1eab9e5 | 56 |
java.util.UUID:6b992f35-2037-44f4-9fef-89389b49696e | 13 |
java.util.UUID:1a2e9053-fa27-4470-9199-31a61372a9cf | 12 |
Top country views
views | |
---|---|
United States | 209 |
Germany | 7 |
Sweden | 7 |
Ukraine | 6 |
United Kingdom | 4 |
Russia | 4 |
Canada | 2 |
China | 2 |
Vietnam | 2 |
Malaysia | 1 |
Top city views
views | |
---|---|
Wilmington | 53 |
Fairfield | 26 |
Houston | 22 |
Ann Arbor | 18 |
Washington | 11 |
Cambridge | 8 |
Jacksonville | 7 |
Kiev | 6 |
Kiez | 6 |
Stockholm | 6 |
Saint Petersburg | 4 |
San Francisco | 4 |
Lima | 3 |
Overland Park | 3 |
Abingdon | 2 |
Beijing | 2 |
Concord | 2 |
Dong Ket | 2 |
Indianapolis | 2 |
Toronto | 2 |
White Plains | 2 |
Bloomsbury | 1 |
Brooklyn | 1 |
Chicago | 1 |
Gunzenhausen | 1 |
Kalmar | 1 |
London | 1 |
Philadelphia | 1 |
Scottsdale | 1 |
Seattle | 1 |
Seremban | 1 |